Safety, and Efficacy of Teclistamab in Patients with Relapsed and Refractory Multiple Myeloma.

Authors
Category Primary study
Registry of TrialsClinical Trials Registry - India
Year 2026
This article has no abstract
Epistemonikos ID: 34c19f23ab122495fbbdec26d5028c63bf2c9538
First added on: Oct 10, 2026